RedHill Biopharma (RDHL) Tops Q1 Loss Views
RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.06), $0.52 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.06), $0.52 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.